Correlation Between Mereo BioPharma and Akero Therapeutics
Can any of the company-specific risk be diversified away by investing in both Mereo BioPharma and Akero Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mereo BioPharma and Akero Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mereo BioPharma Group and Akero Therapeutics, you can compare the effects of market volatilities on Mereo BioPharma and Akero Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mereo BioPharma with a short position of Akero Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mereo BioPharma and Akero Therapeutics.
Diversification Opportunities for Mereo BioPharma and Akero Therapeutics
-0.34 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Mereo and Akero is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding Mereo BioPharma Group and Akero Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Akero Therapeutics and Mereo BioPharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mereo BioPharma Group are associated (or correlated) with Akero Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Akero Therapeutics has no effect on the direction of Mereo BioPharma i.e., Mereo BioPharma and Akero Therapeutics go up and down completely randomly.
Pair Corralation between Mereo BioPharma and Akero Therapeutics
Given the investment horizon of 90 days Mereo BioPharma Group is expected to under-perform the Akero Therapeutics. In addition to that, Mereo BioPharma is 1.28 times more volatile than Akero Therapeutics. It trades about -0.09 of its total potential returns per unit of risk. Akero Therapeutics is currently generating about -0.09 per unit of volatility. If you would invest 3,304 in Akero Therapeutics on September 12, 2024 and sell it today you would lose (240.00) from holding Akero Therapeutics or give up 7.26% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Mereo BioPharma Group vs. Akero Therapeutics
Performance |
| Timeline |
| Mereo BioPharma Group |
| Akero Therapeutics |
Mereo BioPharma and Akero Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Mereo BioPharma and Akero Therapeutics
The main advantage of trading using opposite Mereo BioPharma and Akero Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mereo BioPharma position performs unexpectedly, Akero Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akero Therapeutics will offset losses from the drop in Akero Therapeutics' long position.| Mereo BioPharma vs. Terns Pharmaceuticals | Mereo BioPharma vs. PDS Biotechnology Corp | Mereo BioPharma vs. Inozyme Pharma | Mereo BioPharma vs. Hookipa Pharma |
| Akero Therapeutics vs. Terns Pharmaceuticals | Akero Therapeutics vs. Madrigal Pharmaceuticals | Akero Therapeutics vs. Inozyme Pharma | Akero Therapeutics vs. Viking Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Complementary Tools
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |